Colon cancer-specific antigen-2 may be used as a detecting and prognostic marker in colorectal cancer: A preliminary observation

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Xue, Gang ^a   Wang, Xiaojuan ^a   Yang, Yong ^a   Liu, Degui ^a   Cheng, Ying ^a   Zhou, Jun ^a   Cao, Yongkuan ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLON CANCER SPECIFIC ANTIGEN 2; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; COLON CANCER-SPECIFIC ANTIGEN 2, HUMAN; NUCLEAR PROTEIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CLINICAL EVALUATION; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; BLOOD; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION; MIDDLE AGED; PROGNOSIS;

ANTIGENS, NEOPLASM; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84899436061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094252     Document Type: Article

References (23)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
3. Atkin WS, Edwards R., Kralj-Hans I, Wooldrage K, Hart AR, et al. (2010) UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 375: 1624-1633.
4. Hawk ET, Levin B (2005) Colorectal cancer prevention. J Clin Oncol 23: 378-391. (Pubitemid 46206885)
5. Labianca R, Merelli B (2010) Screening and diagnosis for colorectal cancer: present and future. Tumori96: 889-901.
6. Smith RA, Cokkinides V, Brooks D, Saslow D, Shah M, et al. (2011) Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 61: 8-30.
7. Walgenbach-Brunagel G, Burger B, Leman ES, Walgenbach KJ, Tolba R, et al. (2008) The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer. J Cell Biochem 104: 286-294.
8. Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, et al. (2007) Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 110: 2119-2152. (Pubitemid 350100734)
9. Meissner HI, Breen N, Klabunde CN, Vernon SW (2006) Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 15: 389-394. (Pubitemid 43342192)
10. Smith RA, Cokkinides V, Eyre HJ (2007) Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin 57: 90-104. (Pubitemid 46535709)
11. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, et al. (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer.NEngl J Med 343: 1603-1607. (Pubitemid 32162983)
12. Mandel JS (2007) Which colorectal cancer screening test is best? J Natl Cancer Inst 99: 1424-1425.
13. Di Cristofaro L, Scarpa M, Angriman I, Perissinotto E, Ruffolo C, et al. (2012) Cost-effectiveness analysis of postoperative surveillance protocols following radical surgery for colorectal cancer. Acta Chir Belg 112: 24-32.
14. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, et al. (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58: 130-160. (Pubitemid 351830299)
15. Yeh CY, Hsieh PS, Chiang JM, Lai CC, Chen JS, et al. (2011) Preoperative carcinoembryonic antigen(CEA) elevation in colorectal cancer. Hepatogastroenterology 58: 1171-1176.
16. Hara M, Sato M, Takahashi H, Takayama S, Takeyama H (2011) Accuracy of monitoring serum carcinoembryonic antigen levels in postoperative stage III colorectal cancer patients is limited to only the first postoperative year. Surg Today 41: 1357-1362.
17. Yang XQ, Chen C, Wang FB, Peng CW, Li Y (2011) Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer. Asian Pac J Cancer Prev 12: 1251-1256.
18. Carpelan-Holmström M, Louhimo J, Stenman UH, Alfthan H, Järvinen H, et al. (2004) CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer. Tumour Biol 25: 228-234. (Pubitemid 40082324)
19. Ghesani M, Belgraier A, Hasni S (2003) Carcinoembryonic antigen (CEA) scan in the diagnosis of recurrent colorectal carcinoma in a patient with increasing CEA levels and inconclusive computed tomographic findings. Clin Nucl Med 28: 608-609. (Pubitemid 38281937)
20. Fey EG, Penman S (1988) Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc. Natl Acad Sci USA 85: 121-125.
21. Brunagel G, Vietmeier BN, Bauer AJ, Schoen RE, Getzenberg RH (2002) Identification of nuclear matrix protein alterations associated with human colon cancer. Cancer Res 62: 2437-2442. (Pubitemid 34411729)
22. Leman ES, Schoen RE, Weissfeld JL, Cannon GW, Sokoll LJ, et al. (2007) Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers. Cancer Res 67: 5600-5605. (Pubitemid 46984988)
23. Knychalski B, Lukieńczuk T(2012) The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer. Pol Przegl Chir 84:86-92.